Eitan Medical

Executive Summary

Eitan Medical is an Israeli med-tech company specializing in smart infusion pumps and a cloud-based digital platform for infusion management. Its flagship Sapphire multi-therapy pump and Avoset pump deliver accurate drug delivery across hospitals, home care, infusion centers, and emergency services, while the Eitan Insights platform provides remote monitoring, analytics, and care-planning tools. The company is privately held and in the commercial stage, operating in a competitive market but differentiating through its connected ecosystem and focus on safety. Eitan Medical targets multiple therapeutic areas including pain management, parenteral nutrition, epidural analgesia, critical care, and oncology infusion. Key risks include market adoption barriers, regulatory hurdles, and competition from established players like Baxter and Becton Dickinson. Opportunities lie in expanding its US presence through FDA clearances and strategic partnerships, as well as leveraging its cloud platform to drive hospital efficiency and patient outcomes. With a growing emphasis on smart infusion systems and interoperability, Eitan Medical is well-positioned to capture market share in the evolving healthcare landscape.

Upcoming Catalysts (preview)

• Q3 2026FDA 510(k) clearance for next-generation Sapphire pump70% success
• Q4 2026Strategic partnership with a major US hospital network60% success
• Q2 2026Launch of Eitan Insights 2.0 with advanced analytics80% success